Colossus is positioned as a leading Western-oriented rare earth project with a clear path to production, backed by international government-backed financing mechanisms.

Viridis’ roadmap includes an environmental impact assessment nearing a preliminary license, ongoing drilling to upgrade resources, and plans for a rare earths research and processing centre with a demo plant expected by early 2026.

Export credit agencies are framed as risk mitigants, aligning national economic interests with private investment in rare earths as strategic infrastructure.

The financing package features support from Brazilian institutions BNDES and FINEP, plus US$30 million of secured private placements, aiming for a Final Investment Decision in the third quarter of 2026.

This comes on the heels of prior Brazilian government-backed backing and a US$30 million capital injection from ORE Investments and Réga Capital, underscoring strong financial backing.

Projected output includes 146 tonnes of combined dysprosium and terbium in the first five years, rising to 156 tonnes annually afterward, with substantial amounts of other rare earths such as samarium, gadolinium, and yttrium.

Viridis aims to move toward final investment decision and early development, leveraging government guarantees and private investment.

Viridis secured a letter of support from France’s Bpifrance export credit agency, enabling eligibility for the GPS financing program to back Colossus.

Bpifrance’s Letter of Support enables GPS program eligibility to back strategic financing for Colossus in Brazil.

Projected EBITDA of about US$2.28 billion over a 20-year mine life, with operating costs around US$6 per kilogram of total rare earths, suggesting strong cost efficiency.

The strategic rationale emphasizes Western diversification of critical minerals, multi-government support, and reduced project risk through validated processing capabilities before full-scale development.

Hatch is progressing the definitive feasibility study toward mid-2026, keeping the project on track for a Q3 2026 FID and subsequent production ramp.